Inside Trade

January 24, 2025

Fentanyl awareness group withdraws petition for Section 301 probe into China’s role  

By Dan Dupont  / December 2, 2024 at 7:30 PM
A group representing families of opioid victims has withdrawn a petition filed with the Office of the U.S. Trade Representative asking for a Section 301 probe of Chinese government support for companies that export fentanyl and precursor chemicals to the U.S. Andrea Thomas, founder of Facing Fentanyl, which led the petition, told Inside U.S. Trade it had been withdrawn “for this administration.” “As we’ve witnessed from recent news reports the incoming administration has connected the dots on the PRC’s...

Not a subscriber?

Request 30 days free access to exclusive, behind-the-scenes reporting on trade policy in the Biden era.